美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioAge Labs Inc.

8.49

-0.1600-1.85%

盤後：8.490.00000.00%19:30 EDT

成交量：67.21萬

成交額：567.86萬

市值：3.90億

市盈率：-3.58

高：8.89

開：8.71

低：8.28

收：8.65

52周最高：25.96

52周最低：4.68

股本：4,589.69萬

流通股本：3,757.56萬

量比：1.61

換手率：1.79%

股息：- -

股息率：- -

每股收益(TTM):-2.3710

每股收益(LYR):-2.2432

淨資產收益率：-28.21%

總資產收益率：-18.47%

市淨率：1.04

市盈率(LYR):-3.78

資料載入中...

總覽公司新聞公告

BioAge Labs宣佈QUEL-DME研究完成首位受試者給藥——新型口服NLRP3抑制劑BGE-102針對糖尿病性黃斑水腫的Ⅱ期臨床試驗正式啓動

禮來(LLY)與BioArctic(BIOA)達成神經系統新藥研發合作盤前小幅揚升0.59%

BioAge Labs宣佈BGE-102概念驗證二期試驗Quell-Cv完成首例患者給藥，該口服NLRP3抑制劑針對心血管風險升高人群

衞材預計阿爾茨海默病突破性藥物Leqembi26財年全球銷售額將達1435億日元

BioAge Labs一季度GAAP每股虧損0.52美元，營收280萬美元

环球市场播报

BioAge Labs Inc. 旗下BGE-102在肥胖症治療中實現突破：120毫克與60毫克劑量組hsCRP中位降幅均超85%

BioAge Labs Inc公布BGE-102一期臨床試驗積極中期數據，計劃2026年上半年啓動2a期試驗

BioAge Labs公布2025財年全年業績及第四季度業務進展

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BIOA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIOA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":8.49,"timestamp":1789156800000,"preClose":8.65,"halted":0,"volume":672078,"hourTrading":{"tag":"盘后","latestPrice":8.49,"preClose":8.49,"latestTime":"19:30 EDT","volume":22237,"amount":188812.6952,"timestamp":1789169408455,"change":0,"changeRate":0,"amplitude":0.010601},"delay":0,"changeRate":-0.01849710982658961,"floatShares":37575608,"shares":45896909,"eps":-2.371024,"marketStatus":"休市中","change":-0.16,"latestTime":"09-11 16:00:00 EDT","open":8.71,"high":8.89,"low":8.28,"amount":5678606.455467,"amplitude":0.07052,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.371024,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":8.65,"preHourTrading":{"tag":"盘前","latestPrice":8.736,"preClose":8.65,"latestTime":"08:34 EDT","volume":526,"amount":4607.513832,"timestamp":1789130087004,"change":0.086,"changeRate":0.009942,"amplitude":0.020751},"postHourTrading":{"tag":"盘后","latestPrice":8.49,"preClose":8.49,"latestTime":"19:30 EDT","volume":22237,"amount":188812.6952,"timestamp":1789169408455,"change":0,"changeRate":0,"amplitude":0.010601},"volumeRatio":1.6067519744420837,"impliedVol":1.2692,"impliedVolPercentile":0.8088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","floatShares":37575608,"roa":"-18.47%","roe":"-28.21%","lyrEps":-2.243207,"volumeRatio":1.6067519744420837,"shares":45896909,"dividePrice":0,"high":8.89,"amplitude":0.07052,"preClose":8.65,"low":8.28,"week52Low":4.68,"pbRate":"1.04","psRate":"37.63","week52High":25.955,"institutionHeld":0,"latestPrice":8.49,"eps":-2.371024,"divideRate":0,"volume":672078,"delay":0,"ttmEps":-2.371024,"open":8.71,"prevYearClose":13.23,"prevWeekClose":9.59,"prevMonthClose":9.5,"prevQuarterClose":24.51,"fiveDayClose":9.5,"twentyDayClose":10.43,"sixtyDayClose":20.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"BIOA","fiscalQuarterEnding":"2026/06","expectedEps":-0.65,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2026-05-08","symbol":"BIOA","fiscalQuarterEnding":"2026/03","expectedEps":-0.71,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2026-03-24","symbol":"BIOA","fiscalQuarterEnding":"2025/12","expectedEps":-0.83,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774324800000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2025-11-06","symbol":"BIOA","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2025-08-06","symbol":"BIOA","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.3333,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":9,"updateTime":1779940800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIOA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIOA","date":"2026-09-11","current":-3.580731,"percent":0.507157,"low":-14.88445,"twenty":-10.372028,"median":-4.342854,"eighty":-2.19764,"high":-1.532635,"avg":-5.895588,"sd":3.940475,"marketCap":397008262},"quantilePoints":[{"date":"2024-09-27","current":-10.065016,"twenty":-9.996853,"median":-9.894609,"eighty":-9.328936,"marketCap":625601139},{"date":"2024-10-04","current":-11.466752,"twenty":-11.453559,"median":-10.988513,"eighty":-9.962772,"marketCap":712727458},{"date":"2024-10-11","current":-11.290848,"twenty":-11.83725,"median":-11.290848,"eighty":-10.377246,"marketCap":701793959},{"date":"2024-10-18","current":-13.247909,"twenty":-12.852074,"median":-11.505231,"eighty":-10.913754,"marketCap":823437060},{"date":"2024-10-25","current":-13.708907,"twenty":-13.699687,"median":-12.032944,"eighty":-11.062173,"marketCap":852090807},{"date":"2024-10-31","current":-14.198716,"twenty":-13.910593,"median":-12.258321,"eighty":-11.163318,"marketCap":882535413},{"date":"2024-11-08","current":-10.411209,"twenty":-13.841443,"median":-12.631325,"eighty":-11.163318,"marketCap":738550334},{"date":"2024-11-15","current":-9.850761,"twenty":-13.741177,"median":-12.203351,"eighty":-10.879672,"marketCap":698793259},{"date":"2024-11-22","current":-9.318711,"twenty":-13.704297,"median":-11.736106,"eighty":-10.071646,"marketCap":661050728},{"date":"2024-11-29","current":-9.500638,"twenty":-13.685857,"median":-11.456511,"eighty":-9.850761,"marketCap":673956274},{"date":"2024-12-06","current":-9.283336,"twenty":-13.657045,"median":-11.290848,"eighty":-9.500638,"marketCap":658541317},{"date":"2024-12-13","current":-2.319571,"twenty":-13.258776,"median":-11.073716,"eighty":-9.298497,"marketCap":164545707},{"date":"2024-12-20","current":-2.612676,"twenty":-13.247909,"median":-10.411209,"eighty":-9.141838,"marketCap":185337975},{"date":"2024-12-27","current":-2.971476,"twenty":-13.224859,"median":-10.152544,"eighty":-7.606575,"marketCap":210790579},{"date":"2025-01-03","current":-2.809763,"twenty":-13.09117,"median":-10.065016,"eighty":-3.032119,"marketCap":199318983},{"date":"2025-01-10","current":-2.572247,"twenty":-12.858367,"median":-9.894609,"eighty":-2.886577,"marketCap":182470076},{"date":"2025-01-17","current":-2.54698,"twenty":-12.632478,"median":-9.680039,"eighty":-2.714757,"marketCap":180677639},{"date":"2025-01-24","current":-2.678371,"twenty":-12.552115,"median":-9.568861,"eighty":-2.625815,"marketCap":189998311},{"date":"2025-01-31","current":-2.415588,"twenty":-12.247327,"median":-9.318711,"eighty":-2.600547,"marketCap":171356967},{"date":"2025-02-07","current":-2.309464,"twenty":-12.16927,"median":-9.263122,"eighty":-2.51868,"marketCap":163828732},{"date":"2025-02-14","current":-2.284196,"twenty":-12.012055,"median":-9.141838,"eighty":-2.417609,"marketCap":162036295},{"date":"2025-02-21","current":-2.223554,"twenty":-11.928501,"median":-8.818412,"eighty":-2.37516,"marketCap":157734447},{"date":"2025-02-28","current":-2.208393,"twenty":-11.54371,"median":-3.087708,"eighty":-2.319571,"marketCap":156658985},{"date":"2025-03-07","current":-2.269035,"twenty":-11.466752,"median":-2.971476,"eighty":-2.294303,"marketCap":160960833},{"date":"2025-03-14","current":-2.122483,"twenty":-11.446271,"median":-2.893147,"eighty":-2.269035,"marketCap":150564699},{"date":"2025-03-21","current":-2.208204,"twenty":-11.43377,"median":-2.779442,"eighty":-2.233661,"marketCap":157023162},{"date":"2025-03-28","current":-1.956126,"twenty":-11.290848,"median":-2.7188,"eighty":-2.233661,"marketCap":139098143},{"date":"2025-04-04","current":-1.714131,"twenty":-11.203915,"median":-2.693532,"eighty":-2.213447,"marketCap":121890125},{"date":"2025-04-11","current":-1.729255,"twenty":-11.131435,"median":-2.645523,"eighty":-2.198286,"marketCap":122965626},{"date":"2025-04-17","current":-1.890585,"twenty":-11.039085,"median":-2.589935,"eighty":-2.192221,"marketCap":134437638},{"date":"2025-04-25","current":-2.117456,"twenty":-10.879672,"median":-2.54698,"eighty":-2.170997,"marketCap":150570155},{"date":"2025-05-02","current":-2.087206,"twenty":-10.498085,"median":-2.486337,"eighty":-2.155781,"marketCap":148419153},{"date":"2025-05-09","current":-2.073948,"twenty":-10.229442,"median":-2.420641,"eighty":-2.117456,"marketCap":147343652},{"date":"2025-05-16","current":-1.927611,"twenty":-10.158835,"median":-2.377687,"eighty":-2.112406,"marketCap":136947141},{"date":"2025-05-23","current":-2.038626,"twenty":-10.109042,"median":-2.344838,"eighty":-2.086198,"marketCap":144834149},{"date":"2025-05-30","current":-2.008349,"twenty":-10.078276,"median":-2.334731,"eighty":-2.073148,"marketCap":142683147},{"date":"2025-06-06","current":-2.24047,"twenty":-9.99928,"median":-2.314518,"eighty":-2.051746,"marketCap":159174164},{"date":"2025-06-13","current":-2.2657,"twenty":-9.918948,"median":-2.294303,"eighty":-2.064674,"marketCap":160966666},{"date":"2025-06-20","current":-2.215239,"twenty":-9.87707,"median":-2.284196,"eighty":-2.072748,"marketCap":157381662},{"date":"2025-06-27","current":-2.200101,"twenty":-9.785504,"median":-2.271562,"eighty":-2.073948,"marketCap":156306161},{"date":"2025-07-03","current":-2.159732,"twenty":-9.684587,"median":-2.26468,"eighty":-2.075591,"marketCap":153438158},{"date":"2025-07-11","current":-2.361576,"twenty":-9.665383,"median":-2.263661,"eighty":-2.08254,"marketCap":167778173},{"date":"2025-07-18","current":-2.422129,"twenty":-9.609795,"median":-2.271562,"eighty":-2.08404,"marketCap":172080177},{"date":"2025-07-25","current":-2.371668,"twenty":-9.500638,"median":-2.280838,"eighty":-2.084673,"marketCap":168495173},{"date":"2025-08-01","current":-2.220285,"twenty":-9.464253,"median":-2.280838,"eighty":-2.088197,"marketCap":157740162},{"date":"2025-08-08","current":-1.959737,"twenty":-9.314668,"median":-2.269035,"eighty":-2.084673,"marketCap":154872159},{"date":"2025-08-15","current":-2.023247,"twenty":-9.295465,"median":-2.262157,"eighty":-2.074957,"marketCap":159891165},{"date":"2025-08-22","current":-2.041393,"twenty":-9.27525,"median":-2.258928,"eighty":-2.064982,"marketCap":161325166},{"date":"2025-08-29","current":-2.177486,"twenty":-9.225726,"median":-2.244642,"eighty":-2.064982,"marketCap":172080177},{"date":"2025-09-05","current":-2.136658,"twenty":-9.156998,"median":-2.24047,"eighty":-2.068612,"marketCap":168853674},{"date":"2025-09-12","current":-2.227387,"twenty":-9.141838,"median":-2.24047,"eighty":-2.071948,"marketCap":176023681},{"date":"2025-09-19","current":-2.368016,"twenty":-8.95182,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-09-26","current":-2.368016,"twenty":-8.818412,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-10-03","current":-2.676493,"twenty":-8.732502,"median":-2.244642,"eighty":-2.078994,"marketCap":211515218},{"date":"2025-10-10","current":-2.472354,"twenty":-3.102868,"median":-2.258928,"eighty":-2.082165,"marketCap":195382701},{"date":"2025-10-17","current":-2.318115,"twenty":-3.072547,"median":-2.260654,"eighty":-2.08404,"marketCap":183193689},{"date":"2025-10-24","current":-3.606461,"twenty":-3.072547,"median":-2.2657,"eighty":-2.08404,"marketCap":285007794},{"date":"2025-10-31","current":-3.50666,"twenty":-3.483977,"median":-2.271562,"eighty":-2.087206,"marketCap":277120786},{"date":"2025-11-07","current":-3.533398,"twenty":-3.483977,"median":-2.280838,"eighty":-2.091294,"marketCap":267799776},{"date":"2025-11-14","current":-3.65216,"twenty":-3.543352,"median":-2.287377,"eighty":-2.091294,"marketCap":276800885},{"date":"2025-11-21","current":-4.063738,"twenty":-3.690007,"median":-2.299357,"eighty":-2.092162,"marketCap":307994767},{"date":"2025-11-28","current":-4.489508,"twenty":-3.899107,"median":-2.309042,"eighty":-2.092231,"marketCap":340264301},{"date":"2025-12-05","current":-4.967317,"twenty":-4.069415,"median":-2.318115,"eighty":-2.105866,"marketCap":376477888},{"date":"2025-12-12","current":-6.031742,"twenty":-4.3315,"median":-2.319571,"eighty":-2.109405,"marketCap":457151721},{"date":"2025-12-19","current":-5.856703,"twenty":-5.07234,"median":-2.333015,"eighty":-2.111789,"marketCap":443885358},{"date":"2025-12-26","current":-6.660935,"twenty":-5.750734,"median":-2.336346,"eighty":-2.112399,"marketCap":504838920},{"date":"2026-01-02","current":-6.258819,"twenty":-5.908741,"median":-2.336346,"eighty":-2.11442,"marketCap":474362139},{"date":"2026-01-09","current":-6.585243,"twenty":-6.05445,"median":-2.344838,"eighty":-2.11744,"marketCap":499102115},{"date":"2026-01-16","current":-10.175903,"twenty":-6.388442,"median":-2.355734,"eighty":-2.117456,"marketCap":771241845},{"date":"2026-01-23","current":-10.411813,"twenty":-6.562534,"median":-2.368016,"eighty":-2.117456,"marketCap":789121720},{"date":"2026-01-30","current":-10.521991,"twenty":-6.660935,"median":-2.37516,"eighty":-2.117837,"marketCap":797472215},{"date":"2026-02-06","current":-11.006774,"twenty":-8.674889,"median":-2.403126,"eighty":-2.119987,"marketCap":834214390},{"date":"2026-02-13","current":-10.984738,"twenty":-9.153966,"median":-2.415588,"eighty":-2.124502,"marketCap":832544291},{"date":"2026-02-20","current":-11.094916,"twenty":-9.298497,"median":-2.422129,"eighty":-2.13258,"marketCap":840894786},{"date":"2026-02-27","current":-12.295855,"twenty":-9.537248,"median":-2.429257,"eighty":-2.136658,"marketCap":931915175},{"date":"2026-03-06","current":-11.22713,"twenty":-9.787979,"median":-2.458744,"eighty":-2.147751,"marketCap":850915379},{"date":"2026-03-13","current":-10.954439,"twenty":-10.064753,"median":-2.474292,"eighty":-2.150267,"marketCap":830247905},{"date":"2026-03-20","current":-11.590717,"twenty":-10.152544,"median":-2.496444,"eighty":-2.150267,"marketCap":878472010},{"date":"2026-03-27","current":-8.946976,"twenty":-10.175903,"median":-2.526002,"eighty":-2.154686,"marketCap":721170986},{"date":"2026-04-02","current":-9.761839,"twenty":-10.157216,"median":-2.545959,"eighty":-2.157168,"marketCap":786853020},{"date":"2026-04-10","current":-9.794874,"twenty":-10.109042,"median":-2.572155,"eighty":-2.15903,"marketCap":789515805},{"date":"2026-04-17","current":-9.354407,"twenty":-10.088448,"median":-2.581791,"eighty":-2.159654,"marketCap":754012003},{"date":"2026-04-24","current":-9.492053,"twenty":-10.157216,"median":-2.612676,"eighty":-2.159732,"marketCap":765106941},{"date":"2026-05-01","current":-9.281102,"twenty":-10.117474,"median":-2.677432,"eighty":-2.159732,"marketCap":748103216},{"date":"2026-05-08","current":-9.815385,"twenty":-10.117474,"median":-2.685566,"eighty":-2.162275,"marketCap":791169098},{"date":"2026-05-15","current":-9.250894,"twenty":-10.100274,"median":-2.711219,"eighty":-2.168441,"marketCap":831932916},{"date":"2026-05-22","current":-8.274644,"twenty":-10.088448,"median":-2.728907,"eighty":-2.172379,"marketCap":744138767},{"date":"2026-05-29","current":-8.427879,"twenty":-10.073417,"median":-2.779442,"eighty":-2.173018,"marketCap":757919114},{"date":"2026-06-05","current":-8.413049,"twenty":-10.064858,"median":-2.893147,"eighty":-2.175699,"marketCap":756585532},{"date":"2026-06-12","current":-8.131296,"twenty":-9.999175,"median":-2.971476,"eighty":-2.177486,"marketCap":731247474},{"date":"2026-06-18","current":-9.881131,"twenty":-10.021034,"median":-3.072547,"eighty":-2.177486,"marketCap":888610152},{"date":"2026-06-26","current":-11.18115,"twenty":-10.10449,"median":-3.377371,"eighty":-2.17969,"marketCap":1005520843},{"date":"2026-07-02","current":-11.991808,"twenty":-10.16483,"median":-3.4182,"eighty":-2.183022,"marketCap":1078423326},{"date":"2026-07-10","current":-12.30322,"twenty":-10.247258,"median":-3.447686,"eighty":-2.183492,"marketCap":1106428549},{"date":"2026-07-17","current":-10.953771,"twenty":-10.359979,"median":-3.495318,"eighty":-2.185281,"marketCap":985072585},{"date":"2026-07-24","current":-10.825252,"twenty":-10.509871,"median":-3.543352,"eighty":-2.186883,"marketCap":973514874},{"date":"2026-07-31","current":-12.283448,"twenty":-10.632169,"median":-3.606461,"eighty":-2.188179,"marketCap":1104650439},{"date":"2026-08-07","current":-5.30342,"twenty":-10.612701,"median":-3.697103,"eighty":-2.190009,"marketCap":500982312},{"date":"2026-08-14","current":-5.067589,"twenty":-10.521991,"median":-3.898161,"eighty":-2.190009,"marketCap":478704760},{"date":"2026-08-21","current":-4.708048,"twenty":-10.461393,"median":-3.973853,"eighty":-2.193232,"marketCap":444741048},{"date":"2026-08-28","current":-4.897536,"twenty":-10.411813,"median":-4.092123,"eighty":-2.193232,"marketCap":462640842},{"date":"2026-09-04","current":-4.615733,"twenty":-10.411209,"median":-4.290815,"eighty":-2.195055,"marketCap":436020635},{"date":"2026-09-11","current":-4.202747,"twenty":-10.372028,"median":-4.342854,"eighty":-2.19764,"marketCap":397008262}],"updateTime":1789340196912},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1150534750","title":"BioAge Labs宣佈QUEL-DME研究完成首位受試者給藥——新型口服NLRP3抑制劑BGE-102針對糖尿病性黃斑水腫的Ⅱ期臨床試驗正式啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=1150534750","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150534750?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868874,"startTime":"0","endTime":"0","summary":"BioAge Labs日前宣布，其在研新型口服NLRP3抑制剂BGE-102的Ⅱ期临床试验QUEL-DME已顺利完成首位受试者给药。该试验旨在评估这一创新候选药物在糖尿病性黄斑水肿患者中的疗效与安全性。此次里程碑式的进展，标志着BioAge Labs在推进口服小分子抗炎疗法治疗眼科疾病方面迈出了关键一步。糖尿病性黄斑水肿是糖尿病视网膜病变中导致视力损害的重要原因，长期以来一直是眼科治疗领域亟待满足的临床需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645280260","title":"禮來(LLY)與BioArctic(BIOA)達成神經系統新藥研發合作 盤前小幅揚升0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645280260","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645280260?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 17:16","pubTimestamp":1782119804,"startTime":"0","endTime":"0","summary":"根据协议条款，BioArctic将获得3000万美元的首付款。随着研发、监管和商业化进程的推进，BioArctic还有资格获得最高达7.7亿美元的潜在里程碑付款。在本次合作中，BioArctic将负责把其BrainTransporter技术与礼来拥有自主产权的一款尚未公开的药物分子相结合，共同培育出新型候选药物。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/ODI2NGE1NjlmODgxZDI1NzFmMmQ4ODQzNDA1OTI5NjU2Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ODI2NGE1NjlmODgxZDI1NzFmMmQ4ODQzNDA1OTI5NjU2Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301727","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BK4W5M84.HKD","LU0094547139.USD","LU0203201768.USD","SG9999014898.SGD","LU1814569148.SGD","LU0354030438.USD","LU2112291526.USD","BK4581","LU0158827781.USD","LU1127390331.HKD","LU0787776722.HKD","LU1145028129.USD","LU0882574139.USD","LU1548497426.USD","LU0889565916.HKD","LU0320765059.SGD","IE0002141913.USD","SGXZ99366536.SGD","SGXZ81514606.USD","LU0964807845.USD","LU1917777945.USD","LU2552382058.USD","LU2213496289.HKD","IE0005OL40V9.USD","LU2023250330.USD","LU2063271972.USD","LU0210536198.USD","LU2108987350.USD","LU1093756325.SGD","IE00BKPKM429.USD","SG9999018857.SGD","LU0466842654.USD","LU1069344957.HKD","IE00BFSS7M15.SGD","IE00BWXC8680.SGD","LU2750360641.GBP","SG9999017495.SGD","SG9999014906.USD","LU0198837287.USD","SGXZ57979304.SGD","BK4007","LU1035775433.USD","LU2168564149.EUR","LU0823434583.USD","GB00BDT5M118.USD","LU2237443465.HKD","LU1061106388.HKD","LU2237438978.USD","LU0456855351.SGD","LU2746668974.SGD","LU2264538146.SGD","BK4599","LU1232071149.USD","LU0353189680.USD","LU1057294990.SGD","LU0354030511.USD","IE00B4JS1V06.HKD","LU0882574055.USD","LU2237443895.HKD","IE00BJT1NW94.SGD","SG9999015945.SGD","LU0417517546.SGD","LU0471298694.HKD","LU0256863811.USD","LU0238689110.USD","LU0471298777.SGD","LU1720051017.SGD","LU2087625088.SGD","LU2552382215.SGD","LU2168564495.EUR","LU1064131342.USD","LU2324357040.USD","LU1623119135.USD","IE00B4R5TH58.HKD","LU2417539215.USD","LU0234572021.USD","LU2471134796.USD","SG9999015952.SGD","LU0385154629.USD","LU2461242641.AUD","LU2168564065.EUR","LU1023059063.AUD","LU2361045086.USD","LU0820561909.HKD","LU2471134523.USD","LU2271345857.HKD","LU2896262040.SGD","LU0432979614.USD","LU0097036916.USD","LU1983299246.USD","SG9999013999.USD","LU0225283273.USD","LU1323610961.USD","LU0158827948.USD","LU0316494557.USD","LU0823416689.USD","LU2471134879.HKD","IE00BFSS8Q28.SGD","LU2552382132.HKD","LU0683600562.USD","LU1280957306.USD","LLYZ","SG9999014880.SGD","LU2265009873.SGD","LU0109394709.USD","LU1988902786.USD","LU0114720955.EUR","LU1974910355.USD","LU0786609619.USD","LU2089283258.USD","LU1267930730.SGD","LU2168563687.JPY","LU1868836914.USD","LU2357305700.SGD","LU2168564222.USD","IE00B775H168.HKD","LU0353189763.USD","LU2471134952.CNY","LU2750360997.AUD","LU0122379950.USD","ELIS","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU0820561818.USD","BK4588","SG9999015978.USD","IE00B1XK9C88.USD","LU1366192091.USD","BK4533","LU2089284900.SGD","LU2491049909.HKD","LU0266013472.USD","LU0106261372.USD","SGXZ31699556.SGD","LU2756315664.SGD","LU0133085943.USD","SG9999014914.USD","LU0640476718.USD","LU0289739699.SGD","LU0109391861.USD","SG9999001176.USD","IE00BK4W5L77.USD","LU1629891620.HKD","BIOA","LU1291159041.SGD","IE00BN29S564.USD","LU1868837136.USD","LU1551013342.USD","LU1868836591.USD","IE0009355771.USD","LU1804176565.USD","BK4534","BK4585","LU0672654240.SGD","LU1551013425.SGD","LU2361044865.SGD","LU2462157665.USD","LU2602419157.SGD","SG9999018865.SGD","LU0256863902.USD","LU0203202063.USD","LU2023250504.SGD","IE00B1BXHZ80.USD","LU2361044949.HKD","LU2746668461.USD","IE00BJJMRZ35.SGD","LU1712237335.SGD","LU0079474960.USD","SGXZ51526630.SGD","ELIL","LU2468319806.SGD","LU2237443978.SGD","IE0004445239.USD","LU0823434740.USD","BK4516","LU2237443549.SGD","LU1868836757.USD","LU0061475181.USD","LU0708995401.HKD","IE00B7KXQ091.USD","LU0820562030.AUD","LU2023251221.USD","IE00BKDWB100.SGD","LLYX","LU2106854487.HKD","LU1093756168.USD","SG9999001176.SGD","LLY","LU0058720904.USD","LU2456880835.USD","LU2491050071.SGD","LU0323591593.USD","LU1720051108.HKD","IE00BJLML261.HKD","IE0001KFT4U8.USD","LU0096364046.USD","LU1989771016.USD","LU2028103732.USD","IE00BJJMRX11.SGD","IE00BJJMRY28.SGD","LU0943347566.SGD","LLII","LU2236285917.USD","LU2491050154.USD","IE00B2B36J28.USD","LU2237443622.USD","LU2111349929.HKD","LU2211815571.USD","LU1868837300.USD","LU0006306889.USD","LU2237443382.USD","LU2360106947.USD","SG9999015986.USD","LU2756315318.SGD","IE0004445015.USD","LU2089984988.USD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121020714","title":"BioAge Labs宣佈BGE-102概念驗證二期試驗Quell-Cv完成首例患者給藥，該口服NLRP3抑制劑針對心血管風險升高人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1121020714","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121020714?lang=zh_tw&edition=fundamental","pubTime":"2026-06-16 20:01","pubTimestamp":1781611260,"startTime":"0","endTime":"0","summary":"BioAge Labs公司宣布，其新型口服NLRP3抑制剂BGE-102的概念验证二期临床试验Quell-Cv，已成功为第一位参与者完成给药。该试验主要面向心血管风险升高的患者群体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635707515","title":"衞材預計阿爾茨海默病突破性藥物Leqembi26財年全球銷售額將達1435億日元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635707515","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635707515?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 17:01","pubTimestamp":1778835693,"startTime":"0","endTime":"0","summary":"卫材预计，2026财年Leqembi的全球销售额将达到1435亿日元，较上一财年大幅增长63%。卫材表示，受全球老龄化需求驱动及多国获批上市影响，Leqembi在2026财年将迎来业绩爆发期，预计销售额同比激增六成以上。基于双方的合作协议，BioArctic预计在2026财年将获得约8.8亿瑞典克朗的特许权使用费收入，Leqembi目前已在包括中国、美国、日本和英国在内的53个国家获批。它是全球首款被证明能有效减缓早期阿尔茨海默病认知衰退的疗法。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300481","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001143.SGD","SG9999002521.SGD","B","LU0654597011.USD","LU1023059493.AUD","BK4007","BK4132","LU0330918003.SGD","LU0055631609.USD","LU0788109121.HKD","LU0630314457.HKD","LU0496367417.USD","LU0498741114.HKD","LU0788108826.HKD","BIOA","BK4161","LU0612318385.USD","LU0075056555.USD","LU0300736492.USD","LU0345781412.USD","BK4017","AD","LU0368265764.SGD","LU0498741890.SGD","LU0345780281.USD","LU0724618789.USD","LU0345780521.USD","LU0612318971.USD","LU1430597077.USD","LU0300736062.USD","LU0345780950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633450364","title":"BioAge Labs一季度GAAP每股虧損0.52美元，營收280萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633450364","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633450364?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 22:45","pubTimestamp":1778251500,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司BioAge Labs公布2026年第一季度财报，GAAP每股亏损0.52美元，营收280万美元。业绩符合公司此前给出的指引区间。　　财报显示，公司一季度净亏损约2100万美元，较上年同期净亏损1800万美元有所扩大。研发费用为1800万美元，同比增长15%，主要因主打药物BGE-303治疗肥胖症的二期临床试验推进。　　首席执行官在声明中表示，BGE-303的二期临床试验进展顺利，公司对数据充满期待。　　财报发布后，BioAge股价在盘后交易中上涨约2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-08/doc-inhxfanc4135134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["UUP","BIOA","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100274337","title":"BioAge Labs Inc. 旗下BGE-102在肥胖症治療中實現突破：120毫克與60毫克劑量組hsCRP中位降幅均超85%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100274337","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100274337?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 19:06","pubTimestamp":1776769561,"startTime":"0","endTime":"0","summary":"生物医药公司BioAge Labs Inc. 近日公布其核心候选药物BGE-102在肥胖症领域的积极数据。临床研究结果显示，无论是120毫克还是60毫克剂量组，BGE-102均展现出卓越的疗效，能够将超敏C反应蛋白（hsCRP）的中位水平显著降低，降幅达到或超过85%这一关键阈值。\nhsCRP作为体内炎症的关键生物标志物，其水平与肥胖相关的代谢紊乱及心血管疾病风险密切相关。此次数据表明，BGE-102在有效调控炎症通路方面潜力巨大，为肥胖及其并发症的治疗提供了新的可能方向。这一成果不仅验证了药物的作用机制，也为其后续临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152765977","title":"BioAge Labs Inc公布BGE-102一期臨床試驗積極中期數據，計劃2026年上半年啓動2a期試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1152765977","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152765977?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 21:10","pubTimestamp":1774357815,"startTime":"0","endTime":"0","summary":"生物制药公司BioAge Labs Inc近日披露了其候选药物BGE-102的一期临床试验积极中期结果。数据显示，该药物在安全性及耐受性方面表现良好，为后续临床开发奠定基础。\n公司宣布，基于当前数据进展，计划于2026年上半年启动针对特定适应症的2a期临床试验。这一时间表反映出企业正按既定战略推进该药物的临床开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126957664","title":"BioAge Labs公布2025財年全年業績及第四季度業務進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1126957664","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126957664?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 21:01","pubTimestamp":1774357275,"startTime":"0","endTime":"0","summary":"生物科技公司BioAge Labs Inc.近日披露了2025财年完整财务数据，并同步分享了第四季度关键业务动态。财报显示，公司在报告期内持续推进核心研发项目，并在临床研究方面取得阶段性成果。管理层表示，未来将聚焦于管线药物的商业化布局，同时优化资本结构以支持长期发展战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}